CashuPTC Therapeutics Boosts Talent Acquisition with Stock Options and RSUs for New Employees6 days ago
CashuUniQure Faces FDA Scrutiny Over Huntington's Gene Therapy Amid Controversy and Ethical Concerns12 days ago
prnewswire.comPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)6 days ago
cnbc.comFDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's disease14 days ago
prnewswire.comPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2 months ago
prnewswire.comPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)3 months ago
prnewswire.comPTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference3 months ago
prnewswire.comPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)4 months ago